Department of Intensive Care Unit (ICU), Xianhu Branch of The First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine, Nanning City, the Guangxi Zhuang Autonomous Region, China.
Eur Rev Med Pharmacol Sci. 2020 May;24(10):5618-5626. doi: 10.26355/eurrev_202005_21349.
Acute lung injury (ALI) is one of the most serious complications of sepsis and remains refractory. It is of great significance to discuss the pathogenesis of acute lung injury in sepsis and look for more effective drugs for treatment. The purpose of this study was to investigate the role of LincRNA-p21 on acute lung injury in sepsis.
Lung histology was detected by HE staining to evaluate sepsis-induced ALI model in rats. The miRNA expression of LincRNA-p21 in septic model in vivo and in vitro was detected by RT-qPCR. Cell apoptosis, inflammatory responses and oxidative stress were detected to uncover the influence of LincRNA-p21 on LPS-induced septic model in vitro.
The expression of LincRNA-p21 was significantly increased in septic model in vivo and in vitro. Cell apoptosis, inflammatory responses and oxidative stress were alleviated by LincRNA-p21 interference in LPS-treated BEAS-2B cells.
All the results in the current study proved that LincRNA-p21 interference could alleviate the acute lung injury in septic model. It raised the conclusion that LincRNA-p21 may act as a novel regulator in the pathological process and a potential therapeutic target in sepsis-induced ALI.
急性肺损伤(ALI)是脓毒症最严重的并发症之一,且仍然难以治疗。探讨脓毒症中急性肺损伤的发病机制并寻找更有效的治疗药物具有重要意义。本研究旨在探讨 LincRNA-p21 在脓毒症性急性肺损伤中的作用。
通过 HE 染色检测肺组织学,以评估大鼠脓毒症诱导的 ALI 模型。采用 RT-qPCR 检测体内和体外脓毒症模型中 LincRNA-p21 的 miRNA 表达。检测细胞凋亡、炎症反应和氧化应激,以揭示 LincRNA-p21 对 LPS 诱导的体外脓毒症模型的影响。
LincRNA-p21 在体内和体外脓毒症模型中的表达均显著增加。LincRNA-p21 干扰可减轻 LPS 处理的 BEAS-2B 细胞中的细胞凋亡、炎症反应和氧化应激。
本研究的所有结果均证明 LincRNA-p21 干扰可减轻脓毒症模型中的急性肺损伤。这表明 LincRNA-p21 可能作为脓毒症诱导的 ALI 病理过程中的新型调节剂和潜在的治疗靶点。